Erroneous laboratory results: what clinicians need to know

被引:37
作者
Ismail, Yasmin
Ismail, Abbas A.
Ismail, Adel A. A.
机构
[1] Severn and Wessex Deanery, Bristol
[2] Stepping Hill Hospital, Stockport
[3] Department of Clinical Biochemistry and Chemical Endocrinology, Wakefield
[4] Rheumatology Department, Stepping Hill Hospital
关键词
erroneous analytical results; immunoassay; interference; laboratory tests; wrong laboratory results;
D O I
10.7861/clinmedicine.7-4-357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory tests such as 'conventional biochemistry' are analytically robust and trusted, however, some common tests performed by immunoassays, eg thyroid function tests, are inherently more prone to analytical interference, giving rise to incorrect results. Interfering antibodies capable of causing potentially misleading results in immunoassay varied from about 0.4% to 4%. Furthermore, this form of interference cannot be predicted a priori and cannot be detected even. by most stringent laboratory quality control assurance schemes because it is unique to an individual sample. Since more than 10 million immunoassay tests are carried out yearly in the UK alone, the impact of this problem on delivering appropriate patient care can no longer be ignored. Clinicians tend to perceive all laboratory data in the same light. Because of this, increased awareness of the inherent limitations of these laboratory tests should trigger a more measured and thoughtful approach, thus ensuring patients receive appropriate investigations and treatment.
引用
收藏
页码:357 / 361
页数:5
相关论文
共 22 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]  
BEASTAL GH, 2006, UK GUIDELINES USE TH
[3]  
Bjerner J, 2002, CLIN CHEM, V48, P613
[4]   Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria [J].
Collinson, Paul O. ;
Gaze, David C. ;
Morris, Francis ;
Morris, Brian ;
Price, Alan ;
Goodacre, Steve .
ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 :273-280
[5]   Evidence for the clinical use of tumour markers [J].
Duffy, MJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 :370-377
[6]   Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies [J].
Eriksson, S ;
Halenius, H ;
Pulkki, K ;
Hellman, J ;
Pettersson, K .
CLINICAL CHEMISTRY, 2005, 51 (05) :839-847
[7]  
Fitzmaurice TF, 1998, CLIN CHEM, V44, P2212
[8]   Lesson of the week - In vitro and in vivo haemolysis and potassium measurement [J].
Ismail, A ;
Shingler, W ;
Seneviratne, J ;
Burrows, G .
BRITISH MEDICAL JOURNAL, 2005, 330 (7497) :949-949
[9]   Autoantibodies and specific serum proteins in the diagnosis of rheumatological disorders [J].
Ismail, AA ;
Snowden, N .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :565-578
[10]  
Ismail AAA, 2002, CLIN CHEM, V48, P2023